Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Enbridge Inc (ENB) Price & Performance

ADMA Biologics IncTrade
Enbridge IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Enbridge Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Enbridge Inc trades at $51.74 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 50.7× ADMA Biologics Inc's market cap, and Enbridge Inc pays a 5.34% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMAENB
Market Cap
$2.22B$112.62B
Sector
HealthEnergy
52-Week High
$20.38$58.04
52-Week Low
$7.60$45.23
Enterprise Value
$2.29B$196.53B
Dividend Yield
5.34%

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Enbridge Inc

Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.

Read more on ENB